(Q49118649)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710499%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

YB-1 dependent virotherapy in combination with temozolomide as a multimodal therapy approach to eradicate malignant glioma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710499%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

0 references

Regina Holzmüller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710499%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Klaus Mantwill

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710499%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Cornelia Haczek

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710499%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Martina Anton

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710499%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Atsuko Kasajima

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710499%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Denise Treue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710499%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Hermann Lage

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710499%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Tibor Schuster

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710499%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Jürgen Schlegel

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710499%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Bernd Gänsbacher

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710499%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Per S Holm

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710499%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

English

0 references

publication date

6 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710499%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710499%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710499%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710499%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

1265-1276

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710499%20AND%20SRC:MED&resulttype=core&format=json

The Y-box-binding protein, YB1, is a potential negative regulator of the p53 tumor suppressor

6 February 2020

cites work

1 reference

Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2.

21 January 2018

1 reference

Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression

21 January 2018

1 reference

The RNA binding protein YB-1 binds A/C-rich exon enhancers and stimulates splicing of the CD44 alternative exon v4.

21 January 2018

1 reference

YB-1 as a Cell Cycle-regulated Transcription Factor Facilitating Cyclin A and Cyclin B1 Gene Expression

21 January 2018

1 reference

YB-1 promotes strand separation in vitro of duplex DNA containing either mispaired bases or cisplatin modifications, exhibits endonucleolytic activities and binds several DNA repair proteins

21 January 2018

1 reference

Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition

21 January 2018

1 reference

A p50-like Y-box protein with a putative translational role becomes associated with pre-mRNA concomitant with transcription

21 January 2018

1 reference

Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy

21 January 2018

1 reference

Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1.

21 January 2018

1 reference

Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells

21 January 2018

1 reference

Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents

21 January 2018

1 reference

Optimal role of temozolomide in the treatment of malignant gliomas.

21 January 2018

1 reference

Chemotherapy and novel therapeutic approaches in malignant glioma

21 January 2018

1 reference

AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study

21 January 2018

1 reference

Biology of angiogenesis and invasion in glioma

21 January 2018

1 reference

Immunotherapeutic approaches for glioma

21 January 2018

1 reference

Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme: interim analysis of safety and tolerability

21 January 2018

1 reference

Conditionally replicative adenoviral vectors for malignant glioma.

21 January 2018

1 reference

Multidrug-resistant cancer cells facilitate E1-independent adenoviral replication: impact for cancer gene therapy

21 January 2018

1 reference

YB-1 relocates to the nucleus in adenovirus-infected cells and facilitates viral replication by inducing E2 gene expression through the E2 late promoter

21 January 2018

1 reference

Adenovirus-based virotherapy enabled by cellular YB-1 expression in vitro and in vivo

21 January 2018

1 reference

Deletion of the adenoviral E1b-19kD gene enhances tumor cell killing of a replicating adenoviral vector

21 January 2018

1 reference

Impact of radiation therapy on the oncolytic adenovirus dl520: implications on the treatment of glioblastoma

21 January 2018

1 reference

Design of HIV vectors for efficient gene delivery into human hematopoietic cells

21 January 2018

1 reference

Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector

21 January 2018

1 reference

An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.

21 January 2018

1 reference

Mechanism of activation of early viral transcription by the adenovirus E1A gene product

21 January 2018

1 reference

Binding of heat shock protein 70 to extracellular phosphatidylserine promotes killing of normoxic and hypoxic tumor cells

21 January 2018

1 reference

Y-box-binding protein YB-1 identifies high-risk patients with primary breast cancer benefiting from rapidly cycled tandem high-dose adjuvant chemotherapy

21 January 2018

1 reference

Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.

21 January 2018

1 reference

Use of replicating oncolytic adenoviruses in combination therapy for cancer

21 January 2018

1 reference

Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo

21 January 2018

1 reference

Combining adenoviral oncolysis with temozolomide improves cell killing of melanoma cells

21 January 2018

1 reference

Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter

21 January 2018

1 reference

Inhibition of Y-box binding protein-1 slows the growth of glioblastoma multiforme and sensitizes to temozolomide independent O6-methylguanine-DNA methyltransferase

21 January 2018

1 reference

Targeting angiogenesis: progress with anti-VEGF treatment with large molecules

21 January 2018

1 reference

Oncolytic replication-competent adenovirus suppresses tumor angiogenesis through preserved E1A region.

21 January 2018

1 reference

Salvage therapy with single agent bevacizumab for recurrent glioblastoma.

21 January 2018

1 reference

Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target

21 January 2018

1 reference

Hypoxia-inducible factor-1 inhibition in combination with temozolomide treatment exhibits robust antitumor efficacy in vivo

21 January 2018

1 reference

Effect of hypoxia on Ad5 infection, transgene expression and replication.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.25783

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21710499%20AND%20SRC:MED&resulttype=core&format=json

release_fux7ctvmwvbbxj344vi2c6lete

6 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fux7ctvmwvbbxj344vi2c6lete

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference